(Q70377058)

English

Prevention of follicular maturation in endometriosis by subcutaneous infusion of luteinizing hormone-releasing hormone agonist started in the luteal phase

scientific article published on 01 March 1988

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3125068%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

Prevention of follicular maturation in endometriosis by subcutaneous infusion of luteinizing hormone-releasing hormone agonist started in the luteal phase (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3125068%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

1 reference

based on heuristic

inferred from title

author name string

A Lemay

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3125068%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

J Sandow

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3125068%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

M Bureau

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3125068%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

R Maheux

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3125068%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

J Y Fontaine

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3125068%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

P Mérat

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3125068%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

language of work or name

0 references

publication date

1 March 1988

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3125068%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

Fertility and Sterility

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3125068%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

49

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3125068%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3125068%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

410-417

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3125068%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

Potential new treatment of endometriosis: reversible inhibition of pituitary-ovarian function by chronic intranasal administration of a luteinizing hormone-releasing hormone (LH-RH) agonist

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959764-7

7 January 2021

Gonadotropins and estradiol responses to single intranasal or subcutaneous administration of a luteinizing hormone-releasing hormone agonist in the early follicular phase

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959764-7

7 January 2021

Pituitary and gonadal desensitization after continuous luteinizing hormone-releasing hormone infusion in normal females.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959764-7

7 January 2021

Down-regulation of pituitary gonadotropin secretion in postmenopausal females by continuous gonadotropin-releasing hormone administration

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959764-7

7 January 2021

Toward removing uterine fibroids without surgery: subcutaneous infusion of a luteinizing hormone-releasing hormone agonist commencing in the luteal phase

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959764-7

7 January 2021

Suppression of pituitary and testicular function in normal men by constant gonadotropin-releasing hormone agonist infusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959764-7

7 January 2021

Suppression of follicular maturation by infusion of a luteinizing hormone-releasing hormone agonist starting during the late luteal phase in the stumptailed macaque monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959764-7

7 January 2021

Revised American Fertility Society classification of endometriosis: 1985

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959764-7

7 January 2021

Inhibition of ovulation during discontinuous intranasal luteinizing hormone-releasing hormone agonist dosing in combination with gestagen-induced bleeding

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959764-7

7 January 2021

Antibody production against an agonist analogue of luteinizing hormone-releasing hormone: evaluation of immunochemical and physiological consequences

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959764-7

7 January 2021

Dose-related changes in LH bioactivity with intranasal GnRH agonist administration

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959764-7

7 January 2021

Loss of luteinizing hormone bioactivity in patients with prostatic cancer treated with an LHRH agonist and a pure antiandrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959764-7

7 January 2021

Stimulation of LH fragments with reduced bioactivity following GnRH agonist administration in women

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959764-7

7 January 2021

A luteinizing hormone-releasing hormone agonist decreases biological activity and modifies chromatographic behavior of luteinizing hormone in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959764-7

7 January 2021

Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959764-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Intranasal treatment with luteinising hormone releasing hormone agonist in women with endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2959764-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0015-0282(16)59764-7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3125068%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3125068%20AND%20SRC:MED&resulttype=core&format=json

10 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q70377058&oldid=1984252323"